Barbara Sanders is a co-founder and Chief Technology Officer of VectorY since 2022. As co-founder and CTO, Dr. Sanders spearheads VectorY’s viral vector development efforts.

Dr. Sanders was previously a VP Vector Development during the Company’s inception in 2020. She has over 10 years of experience in viral vector development within large pharmaceutical and biotechnology companies where she led multiple discovery and CMC teams. She has contributed to the successful development of several viral vectored vaccines, including a commercialized Ebola vaccine (Zabdeno) and others which are currently in clinical development for polio, zika, HIV and RSV.

Dr. Sanders completed a Ph.D. in molecular virology at the University of Amsterdam and is an inventor of eight patents.